Global News Feed

Home Bookmarks Preferences World Extract Custom
Total
Unread
Saved
More
Preferences Custom News
Home Saved World Extract
Prev Back to News Next

Novo Nordisk says semaglutide cut obesity rates in young children in trial

Source: Reuters
Category: General
Region: General
Published: September 07, 2026 at 11:03

๐Ÿ“ Summary

Novo Nordisk says semaglutide cut obesity rates in young children in trial Reuters

๐Ÿ”— Read Full Article at Reuters โœจ Extract Article
๐Ÿท๏ธ Keywords:
novo nordisk says semaglutide obesity rates young children trial reuters

๐Ÿ’ฌ Social Media Posts

Click "Fetch Related Posts" to find social media discussions about this article

๐Ÿ“ฐ Related Articles

Novo Nordisk open to direct New York listing, CEO Doustdar tells FT
Reuters ยท Sep 23
Novo Nordisk pursues preliminary injunction to block Eli Lilly weight-loss drug ads
Reuters ยท Jul 24
Novo Nordisk: Es geht es um viel mehr als die Abnehmspritze
FAZ ยท Oct 02
Obesity rates have doubled in England since 1993 - what's going on?
BBC ยท Aug 07
Previous Article Next Article